TLN2 functions as a tumor suppressor in clear cell renal cell carcinoma via inactivation of the Wnt/β-catenin signaling pathway

Jingshuang Cai, Zhiyang Huang, Jin Zhou, Wenfeng Wu, Yanle Ye

Translational Andrology and Urology · 2022 · 15 citations · 19 references

DOIFull text

Open access

Abstract

TLN2 served as a tumor regulator of ccRCC via Wnt/β catenin signaling, suggesting that it could be a promising therapeutic and prognostic biomarker for ccRCC.

References

19